[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609370":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":24,"responsibleParty":108,"collaborators":110,"id":116,"slug":117,"hasResults":118,"nctId":119,"briefTitle":120,"officialTitle":121,"acronym":122,"eligibilityCriteria":123,"healthyVolunteers":118,"sex":124,"minAge":10,"maxAge":10,"enrollmentInfo":125,"targetDuration":128,"studyType":129,"phases":10,"briefSummary":130,"conditions":131,"keywords":136,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":153,"completionDateStruct":155,"leadSponsor":157,"locationsCount":158},{"fullName":5,"class":6},"Stichting International Registry for Alzheimer's Disease and other Dementias Foundation","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Alzheimer's Disease Registry Participants",null,"Individuals diagnosed with Alzheimer's disease or undergoing diagnostic work-up, enrolled in the InRAD Registry for long-term observational follow-up. This cohort includes treated, treatment-eligible, and untreated patients across global clinical centers participating in routine care and data collection.",[13],"Other: None, this is a non-interventional observational study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"None, this is a non-interventional observational study","None applicable",[9],[20],{"name":21,"role":22,"phone":10,"phoneExt":10,"email":23},"Scientific Officer","CONTACT","office@inradnetwork.org",[25,42,56,69,82,94],{"facility":26,"status":27,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"UZLeuven","RECRUITING","Leuven","3000","Belgium","BE",{"type":33,"coordinates":34},"Point",[35,36],4.70093,50.87959,{"lat":36,"lon":35},[39],{"name":40,"role":41,"phone":10,"phoneExt":10,"email":10},"Rik Vandenberghe","PRINCIPAL_INVESTIGATOR",{"facility":43,"status":27,"city":44,"state":10,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":52,"contacts":53},"Irmandade da Santa Casa de São Paulo","São Paulo","01221-010","Brazil","BR",{"type":33,"coordinates":49},[50,51],-46.63611,-23.5475,{"lat":51,"lon":50},[54],{"name":55,"role":41,"phone":10,"phoneExt":10,"email":10},"Diogo Haddad Santos",{"facility":57,"status":27,"city":58,"state":10,"zip":10,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Panhellenic Federation of Alzheimer's Disease and Related Disorders","Thessaloniki","Greece","GR",{"type":33,"coordinates":62},[63,64],22.93493,40.64072,{"lat":64,"lon":63},[67],{"name":68,"role":41,"phone":10,"phoneExt":10,"email":10},"Magda Tsolaki",{"facility":70,"status":27,"city":71,"state":10,"zip":10,"country":72,"countryCode":73,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"B.R.A.N.D. Center - Neurologia Universitaria - Policinico Foggia","Foggia","Italy","IT",{"type":33,"coordinates":75},[76,77],15.55188,41.45845,{"lat":77,"lon":76},[80],{"name":81,"role":41,"phone":10,"phoneExt":10,"email":10},"Emanuele D'Amico",{"facility":83,"status":27,"city":84,"state":10,"zip":85,"country":72,"countryCode":73,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Ospedale San Raffaele","Milan","20132",{"type":33,"coordinates":87},[88,89],9.18951,45.46427,{"lat":89,"lon":88},[92],{"name":93,"role":41,"phone":10,"phoneExt":10,"email":10},"Federica Agosta",{"facility":95,"status":27,"city":96,"state":10,"zip":97,"country":98,"countryCode":99,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"Fundació ACE, Institut Català de Neurociències Aplicades","Barcelona","08028","Spain","ES",{"type":33,"coordinates":101},[102,103],2.15899,41.38879,{"lat":103,"lon":102},[106],{"name":107,"role":41,"phone":10,"phoneExt":10,"email":10},"Mercè Boada",{"type":109,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[111,114],{"name":112,"class":113},"InRAD Foundation (Data Processor)","UNKNOWN",{"name":115,"class":113},"Principal Investigator","100609370","inrad-observational-study-100609370",false,"NCT07213700","InRAD Observational Study","The International Registry for Alzheimer's Disease and Other Dementias (InRAD): An International Registry Observational Study Dedicated to Evaluating Outcomes Data in Alzheimer's Disease","InRAD","Inclusion Criteria:\n\n* Be undergoing diagnostic work-up for Alzheimer's disease (AD), OR\n* Have a confirmed diagnosis of AD (whether currently treated with an AD-specific treatment, or untreated),\n* Be attending an InRAD Center,\n* Have provided informed consent for long-term follow-up\n\nExclusion Criteria:\n\n-Any patient or legal representative who is unable or unwilling to provide a signed informed consent form","ALL",{"count":126,"type":127},50000,"ESTIMATED","10 Years","OBSERVATIONAL","The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across global clinical centers.\n\nThe InRAD Registry Observational Study has several aims:\n\n* To collect medical information for many years from a large group of people with Alzheimer's disease. This will be used for research, which will support improved understanding about the disease.\n* To enable researchers to look at the effectiveness, usefulness and safety of treatments for Alzheimer's disease.\n* To enable researchers to answer similar research questions and compare results in many different areas of the world.\n\nPeople with Alzheimer's disease who meet the eligibility criteria and agree to participate in the Study will be asked to visit their doctor (e.g. psychiatrist, geriatrician, or neurologist) at least once a year, or as frequently as is needed for their care. During or after their appointments they may be offered assessments, tests, medications, and treatments as determined by their doctor and their team. This is an observational data collection.",[132,133,134,135],"Alzheimer's Disease(AD)","Mild Cognitive Impairment (MCI)","Subjective Cognitive Decline (SCD)","Non-Alzheimer Degenerative Dementia",[137,138,139,140,141,142,143,144,145,146,147,148],"Alzheimer's disease (AD)","Dementia","Observational study","Real-world data (RWD)","International registry","Cognitive decline","Lecanemab","InRAD Registry","InRAD Foundation","Cognitive screening (MoCA, MMSE)","AD-specific therapies","Clinical staging","2026-07-01",{"date":151,"type":152},"2026-07-02","ACTUAL",{"date":154,"type":152},"2026-03-30",{"date":156,"type":127},"2036-01",{"name":5,"class":6},6]